biologics
Recipharm designates Germany site as Centre of Excellence
October 9, 2025Research and Development CDMO, Cuxhaven, Recipharm, biologics
The multi-product facility recently underwent significant renovations
Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0
January 17, 2025CPhI, Pharmpack, biologics, predictions
Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025 13 …
Lonza to acquire biologics site in Vacaville, US from Roche for $1.2bn
March 20, 2024Manufacturing and Production Lonza, Pharmacy, Roche, biologics, facility, manufacturing
Lonza has announced that it has signed an agreement to acquire the Genentech large-scale biologics site based in Vacaville, California, …
AstraZeneca to retire MedImmune brand amid restructuring
February 15, 2019Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …
Boehringer injects €230 million in new Biologicals Development Center
June 26, 2018Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma
Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development …
AbbVie adds biologic production capability to Singapore facility
October 4, 2017Manufacturing and Production, Research and Development AbbVie, Singapore, biologics, pharma, pharmaceuticals
AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …
UK’s first commercial synthetic biology foundry begins production
April 7, 2016Manufacturing and Production, Research and Development Biological, biologics, foundry, synbicite
SynbiCITE’s has begun production at the UK’s first commercial synthetic biology foundry. The site provides automated end-to-end design, construction and …
FDA review for Sanofi and Regeneron’s biologic arthritis drug
January 8, 2016Medical Communications, Sales and Marketing FDA, Regeneron, Sanofi, biologics, rheumatoid arthritis, sarilumab
The FDA has accepted for review a Biologics License Application (BLA) from Sanofi and Regeneron for the rheumatoid arthritis treatment …
AstraZeneca deal to delve into the secretome
December 11, 2015Medical Communications, Research and Development AstraZeneca, MedImmune, biologics, secretome
MedImmune, the biologics research and development arm of pharma giant AstraZeneca, has signed a collaboration with Swedish universities and research …
EU plans export waiver for pharma manufacturing
November 3, 2015Manufacturing and Production EGA, European Commission, biologics, biosimilars, generics, manufacturing, supplementary protection certificates
The European Commission plans to bring in an export waiver for supplementary protection certificates, in order to boost pharma industry …
ANALYSIS: The challenges of forecasting biosimilar sales across Europe
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts
The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
AstraZeneca purchases former Amgen US facility
September 15, 2015Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production
AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …
Sanofi and Boehringer partner on biologics manufacturing
January 15, 2015Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology
Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …
BMS expands Samsung deal
April 29, 2014Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon
Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …
Biologics lift for UK
April 22, 2014Manufacturing and Production, Sales and Marketing Cameron, UK, biologics, darlington, nbmc
Work has begun on a key new £38 million centre in Central Park, Darlington, which should increase the biologics capability …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
